Stocktoria

Propanc Biopharma, Inc. PPCB

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2012-06-15 · LEI

Propanc Biopharma, Inc. statistics & valuation

Market cap$3.3M
P / B0.2×
Net debt$537,921
Enterprise value USD$3.9M
Return on capital-407.6%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
2016201720182019202020212022202320242025
Operating margin (%)
2016201720182019202020212022202320242025
Return on equity (%)
-423.70% 2016201720182019202020212022202320242025
Shares outstanding
2.9M 4.6M 92810 967993 258120 14.1M 220351 6.0M 7980 11.6M 2016201720182019202020212022202320242025
Net debt ($)
$1.2M $3.5M $4.7M $1.7M $1.5M $622328 $922371 $390539 $399325 $537921 2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
-2482.00% -8275.60% -9860.60% -5664.80% -4812.00% -15464.10% -3255.40% -4410.20% -2515.80% -300.10% 2016201720182019202020212022202320242025
Free cash flow margin (%)
2016201720182019202020212022202320242025
Debt / equity (×)
0.04× 2016201720182019202020212022202320242025
EPS ($)
-$49.23 -$1.80 -$1420.53 -$14.85 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Return on assets-300.1%-2515.8%-4410.2%-3255.4%-15464.1%-4812.0%-5664.8%-9860.6%-8275.6%-2482.0%
Return on equity-423.7%48.2%85.4%87.9%66.0%130.2%133.9%104.3%144.6%366.8%
Debt / equity0.04×-0.11×-0.13×-0.31×-0.20×-0.43×-0.39×-0.70×-0.64×-0.47×
Current ratio1.500.010.010.000.000.020.020.010.010.12

Computed from company filings · US · as of 2025-06-30. Facts plus Stocktoria's own computed scores — not investment advice.